IDEXX Laboratories, Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG000BLRT07
IDXX
IDEXX Laboratories, Inc.
GICS: -
·
Sector: Healthcare
·
Sub-Sector: Diagnostics & Research
NAME
IDEXX Laboratories, Inc.
ISIN
US45168D1046
TICKER
IDXX
MIC
XNAS
REUTERS
IDXX.OQ
BLOOMBERG
IDXX US
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Mon, 09.12.2024
IDEXX Laboratories
US45168D1046
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that the Company’s Board of Directors authorized an increase in its ongoing share repurchase program, authorizing the repurchase of up to five million additional shares of the Company’s common stock. Repurchases may be made at management’s discre...
IDEXX Laboratories
Thu, 21.11.2024
IDEXX Laboratories
US45168D1046
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon has decided to retire from IDEXX effective June 1, 2025. Andrew Emerson, currently Senior Vice President, Corporate and Companion Animal Group (“CAG”) Finance, will succeed Mr. McKeon as IDEXX’s Executive Vice President, Chief F...
IDEXX Laboratories
Thu, 31.10.2024
IDEXX Laboratories
US45168D1046
In the 2024 Growth and Financial Performance Outlook section, second paragraph, second sentence should read: At midpoint, projected full year comparable operating profit margin expansion of 30 - 60 basis points includes a ~40 basis point negative growth impact from lapping a customer contract resolution payment in the first quarter of 2023. (inste...
IDEXX Laboratories
Thu, 31.10.2024
IDEXX Laboratories
US45168D1046
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results.
Third Quarter Results
The Company reports revenues of $976 million for the third quarter of 2024, an increase of 7% as reported and 6% organic, driven by Companion Animal Group ("CAG") growth of 7% as reported and 6% orga...
IDEXX Laboratories
Mon, 30.09.2024
IDEXX Laboratories
US45168D1046
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 third quarter results for Thursday, October 31, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. EDT on that day.
Individuals can access a live webcast of the confere...
IDEXX Laboratories
Wed, 21.08.2024
IDEXX Laboratories
US45168D1046
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, Sep...
IDEXX Laboratories
Information on product placements
SMART * AD
P R O D U C T S U G G E S T I O N S
